Publications by authors named "A Aylott"

Claim this Profile
S
Safety and tolerability of intramuscular sotrovimab administered at different injection sites: results from the Phase 1 COSMIC study.
Jennifer Moore, Alicia Aylott, Wen-Hung Chen, Jerzy Daniluk, Ian A Hawes

MAbs· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Tolerability and Pharmacokinetics of a High-Dose, Rapid-Infusion Monoclonal Antibody: Phase I Results for Intravenous Sotrovimab 3000 mg.
Yasmin Sánchez-Pearson, Jennifer Moore, Jerzy Daniluk, Sookti Bhangu, Sergio Parra, Alicia Aylott

Drugs R D· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label phase II trial of sotrovimab (VIR-7831) prophylaxis against COVID-19 infection in immunocompromised individuals with impaired SARS-CoV-2 humoral immunity.
Isabel H Gonzalez-Bocco, Rayven Frierson, Alyssa Cho, Fabiola A Reyes Curcio, Andres E Franceschi, Alicia Aylott

New Microbes New Infect· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring the emergence of resistance with sotrovimab in immunocompromised patients with COVID-19: LUNAR study.
Judith Breuer, Myriam Drysdale, Jill Walker, Jennifer Han, Alicia Aylott

J Infect· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and Safety of Single-Dose Sotrovimab in High-Risk Children and Adolescents With Mild-to-Moderate COVID-19.
Jennifer Moore, Daren Austin, Alicia Aylott, Jerzy Daniluk, Leah A Gaffney

J Pediatric Infect Dis Soc· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis